Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
Blood Advances|July 17, 2023
Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-upAlexander Röth, Catherine M Broome, Wilma Barcellini, et al.
Blood Reviews|December 17, 2019
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus MeetingUlrich Jäger, Wilma Barcellini, Catherine M Broome, et al.
Lancet (London, England)|October 1, 2023
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trialCatherine M Broome, Vickie McDonald, Yoshitaka Miyakawa, et al.
Revue Medicale Suisse|April 1, 2009
[Children born with a cleft: treatment at the CHUV in Lausanne]J Hohlfeld, A de Buys Roessingh, G Herzog, et al.
Psychological Medicine|July 29, 2014
Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high riskG Modinos, P Allen, M Frascarelli, et al.
Cancer Genetics and Cytogenetics|February 12, 1999
Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanomaM A Nelson, M E Ariza, J M Yang, et al.
The American Journal of Clinical Nutrition|February 4, 2015
Aerated drinks increase gastric volume and reduce appetite as assessed by MRI: a randomized, balanced, crossover trialKathryn Murray, Elisa Placidi, Ewoud A H Schuring, et al.
European Journal of Haematology|November 20, 2022
Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA studyAlexander Röth, Catherine M Broome, Wilma Barcellini, et al.
Cancer Reports (Hoboken, N.J.)|December 27, 2023
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line settingR Gencheva, M Petrova, P Kraleva, et al.
The New England Journal of Medicine|April 7, 2021
Sutimlimab in Cold Agglutinin DiseaseAlexander Röth, Wilma Barcellini, Shirley D'Sa, et al.
Pageof 23